Clinical Trial Update: Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin

View source ↗

Summary

A completed clinical trial evaluating cardiac magnetic resonance imaging in patients with non-Hodgkin lymphoma or Hodgkin lymphoma receiving doxorubicin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University of Nebraska | Conditions: Cardiac Toxicity, Chemotherapeutic Agent Toxicity | Status: COMPLETED | Results posted: 2023-11-03